Repositioning Candidate Details
| Candidate ID: | R0235 |
| Source ID: | DB00828 |
| Source Type: | approved |
| Compound Type: | small molecule |
| Compound Name: | Fosfomycin |
| Synonyms: | |
| Molecular Formula: | C3H7O4P |
| SMILES: | C[C@@H]1O[C@@H]1P(O)(O)=O |
| Structure: |
|
| DrugBank Description: | An antibiotic produced by Streptomyces fradiae. |
| CAS Number: | 23155-02-4 |
| Molecular Weight: | 138.059 |
| DrugBank Indication: | For the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of <i>Escherichia coli</i> and <i>Enterococcus faecalis</i>. |
| DrugBank Pharmacology: | Fosfomycin is a broad spectrum antibiotic that concentrates in kidney and bladder and is used to treat uncomplicated urinary tract infections. Fosfomycin also reduces nephrotoxicity and ototoxicity of platinum-containing anti-tumor agents. |
| DrugBank MoA: | Fosfomycin is a phosphoenolpyruvate analogue produced by Streptomyces that irreversibly inhibits enolpyruvate transferase (MurA), which prevents the formation of N-acetylmuramic acid, an essential element of the peptidoglycan cell wall. |
| Targets: | UDP-N-acetylglucosamine 1-carboxyvinyltransferase |
| Inclusion Criteria: |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|